Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes
Domizia Baldassi, Shubhankar Ambike, Martin Feuerherd, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 661-674
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery
Hezhi Wang, Qin Lu, Xin Zhang, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 970-993
Open Access | Times Cited: 46
Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management
Sayali Dighe, Sunil Jog, Munira Momin, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 58-58
Open Access | Times Cited: 23
Lung regeneration: diverse cell types and the therapeutic potential
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 10
Strategies and mechanisms for endosomal escape of therapeutic nucleic acids
Melina Grau, Ernst Wagner
Current Opinion in Chemical Biology (2024) Vol. 81, pp. 102506-102506
Open Access | Times Cited: 8
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
Omid Gholizadeh, Saman Yasamineh, Parya Amini, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Selective Replacement of Cholesterol with Cationic Amphiphilic Drugs Enables the Design of Lipid Nanoparticles with Improved RNA Delivery
Bram Bogaert, Aliona Debisschop, Thomas Ehouarne, et al.
Nano Letters (2024) Vol. 24, Iss. 10, pp. 2961-2971
Open Access | Times Cited: 7
Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery
Ricarda C. Steffens, Ernst Wagner
Pharmaceutical Research (2022) Vol. 40, Iss. 1, pp. 47-76
Open Access | Times Cited: 23
Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections
Ching-Yee Loo, Wing‐Hin Lee, Qi Zhou
Pharmaceutical Research (2023) Vol. 40, Iss. 5, pp. 1015-1036
Open Access | Times Cited: 14
Organotypic lung tissue culture as a preclinical model to study host- influenza A viral infection: A case for repurposing of nafamostat mesylate
Pelin Sağlam-Metiner, Ece Yıldız-Ozturk, Aslı Tetik-Vardarli, et al.
Tissue and Cell (2024) Vol. 87, pp. 102319-102319
Closed Access | Times Cited: 4
Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV
Ellen Bowden-Reid, Ernest Moles, Anthony D. Kelleher, et al.
Drug Delivery and Translational Research (2025)
Open Access
Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses
Quynh Xuan Thi Luong, Phuong Thi Hoang, Phuong T. Ho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1481-1481
Open Access
Analysis of Polymer/siRNA Nanoparticle Efficacy and Biocompatibility in 3D Air–Liquid Interface Culture Compared to 2D Cell Culture
Sandra Noske, Martin Krueger, Alexander Ewe, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 339-339
Open Access
Antiviral polymers: Broad spectrum antiviral activity, antiviral mechanisms, and optimization for the treatment of various infections
Imran Hasan, Fahad A. Alharthi, Ashok Kumar Bishoyi, et al.
Journal of Industrial and Engineering Chemistry (2025)
Closed Access
Pulmonary siRNA Delivery with Sophisticated Amphiphilic Poly(Spermine Acrylamides) for the Treatment of Lung Fibrosis
Friederike Adams, Christoph M. Zimmermann, Domizia Baldassi, et al.
Small (2023) Vol. 20, Iss. 22
Open Access | Times Cited: 11
Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections
Maya K. Monroe, Han Wang, Caleb F. Anderson, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 1028-1049
Open Access | Times Cited: 18
Fluorescent Techniques for RNA Detection in Nanoparticles
Simone Pinto Carneiro, Joschka T Müller, Olivia M. Merkel
Methods in molecular biology (2024), pp. 187-203
Closed Access | Times Cited: 3
SARS-CoV-2 replication and drug discovery
Farah Nazir, Arnaud John Kombe Kombe, Zunera Khalid, et al.
Molecular and Cellular Probes (2024) Vol. 77, pp. 101973-101973
Open Access | Times Cited: 3
Nanoparticles for Coronavirus Control
Maryam Kianpour, Mohsen Akbarian, Vladimir N. Uversky
Nanomaterials (2022) Vol. 12, Iss. 9, pp. 1602-1602
Open Access | Times Cited: 14
Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
Mouraya Hussein, Zaria Andrade dos Ramos, Monique Vink, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 686-686
Open Access | Times Cited: 8
SiRNAs as antiviral drugs – Current status, therapeutic potential and challenges.
Trairong Chokwassanasakulkit, Victor B. Oti, Adi Idris, et al.
Antiviral Research (2024), pp. 106024-106024
Open Access | Times Cited: 2
Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection
Jingran Chen, Ying Li, Zhen Liu
Cell Reports Physical Science (2023) Vol. 4, Iss. 2, pp. 101249-101249
Open Access | Times Cited: 6
Can pulmonary RNA delivery improve our pandemic preparedness?
Olivia M. Merkel
Journal of Controlled Release (2022) Vol. 345, pp. 549-556
Open Access | Times Cited: 10
Evaluation of the effects of storage conditions on spray-dried siRNA-LNPs before and after subsequent drying
Christoph M. Zimmermann, Leonie Deßloch, David C. Jürgens, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 193, pp. 218-226
Closed Access | Times Cited: 5
Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery
Domizia Baldassi, Thi My Hanh Ngo, Olivia M. Merkel
Pharmaceutical Research (2022) Vol. 41, Iss. 1, pp. 77-91
Open Access | Times Cited: 8
Evaluation of the effect of RNA secondary structure on Cas13d-mediated target RNA cleavage
Mouraya Hussein, Ye Liu, Monique Vink, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102278-102278
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top